Relationships between G1 Arrest and Stability of the p53 and p21CiP1/Wafl Proteins following y-Irradiation of Human Lymphoma Cells

Cancer Research

Volumn 55, Issue 11, 1995, Pages 2387-2393

  Bae, Insoo ^a   Fan, Saijun ^a   Bhatia, Kishor ^a   Kohn, Kurt W ^a   Fornace, Albert J ^a   O’Connor, Patrick M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MESSENGER RNA; PROTEIN P21; PROTEIN P53; CIP1 PROTEIN; CYCLINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; ONCOPROTEIN; PROTEIN; PROTEIN MDM2; PROTO ONCOGENE PROTEINS;

ARTICLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; GENE ACTIVATION; HUMAN; HUMAN CELL; IONIZING RADIATION; LYMPHOBLASTOID CELL; LYMPHOMA CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; BURKITT LYMPHOMA; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DRUG STABILITY; GAMMA RADIATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LYMPHOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE;

BURKITT LYMPHOMA; CELL LINE; COMPARATIVE STUDY; CYCLINS; DRUG STABILITY; G1 PHASE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMAN; LYMPHOCYTES; PROTEIN P53; PROTEINS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0028978117     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. O’Connor, P. M., and Kohn, K. W. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Semin. Cancer Biol., 3: 409–416, 1992.
2. Smith, M. L., and Fornace, A. J., Jr. Genomic instability and the role of p53 mutations in cancer cells. Curr. Opin. Oncol., 7: 69–75, 1995.
3. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629–634, 1989.
4. 2 arrest induced by nitrogen mustard in human lymphoma cells. Proc. Natl. Acad. Sci. USA, 91: 9480–9484, 1994.
5. Murray, A. W. Creative blocks: cell-cycle checkpoints and feedback controls. Nature (Lond.), 359: 599–604, 1992.
6. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304–6311, 1991.
7. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint utilizing p53 and GADD45 is defective in ataxia telangiectasia. Cell, 71: 587–597, 1992.
8. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491–7495, 1992.
9. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923–935, 1992.
10. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937–948, 1992.
11. O’Connor, P. M., Jackman, J., Jondle, D., Bhatia, K., Magrath, I., and Kohn, K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt’s lymphoma cell lines. Cancer Res., 53: 4776–4780, 1993.
12. Fan, S., El-Deiry, W. S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A. J., Jr., Magrath, I., Kohn, K. W., and O’Connor, P. M. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54: 5824–5830, 1994.
13. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847–849, 1993.
14. Lee, J. M., and Bernstein, A. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA, 90: 5742–5746, 1993.
15. Zambetti, G. P., and Levine, A. J. A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7: 855–865, 1993.
16. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature (Lond.), 362: 857–860, 1993.
17. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817–825, 1993.
18. Fakharzadeh, S. S., Trusko, S. P., and George, D. L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J., 10: 1565–1569, 1991.
19. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237–1245, 1992.
20. Zauberman, A., Barak, Y., Ragimov, N., Levy, N., and Oren, M. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J., 12: 2799–2808, 1993.
21. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7: 1126–1132, 1993.
22. Chen, C. Y., Oliner, J. D., Zhan, Q., Fornace, A. J., Jr., Vogelstein, B., and Kastan, M. B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Nad. Acad. Sci. USA, 91: 2684–2688, 1994.
23. Fornace, A. J., Jr., Nebert, D. W., Hollander, M. C., Luethy, J. D., Papathanasiou, M., Fargnoli, J., and Holbrook, N. J. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol., 9: 4196–4203, 1989.
24. Papathanasiou, M. A., Kerr, N. C., Robbins, J. H., McBride, O. W., Alamo, I. J., Barrett, S. F., Hickson, I. D., and Fornace, A. J., Jr. Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol. Cell. Biol., 11: 1009–1016, 1991.
25. 1 cell cycle checkpoint pathway and ataxia telangiectasia. Cancer Res., 54: 5054–5058, 1994.
26. Zhan, Q., Lord, K. A., Alamo, I. J., Hollander, M. C., Carrier, F., Ron, D., Kohn, K. W., Hoffman, B., Liebermann, D. A., and Fornace, A. J., Jr. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergis-tically suppress cell growth. Mol. Cell. Biol., 14: 2361–2371, 1994.
27. Smith, M. L., Chen, I., Zhan, Q., Bae, I., Chen, C., Gilmer, T., Kastan, M. B., O’Connor, P. M., and Fornace, A. J., Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (Washington DC), 266: 1376–1380, 1994.
28. Smith, M. L., Chen, I. T., Zhan, Q., O’Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene, 10: 1053–1059, 1995.
29. Hollander, M. C., Alamo, I., Jackman, J., McBride, O. W., and Fornace, A. J., Jr. Sequence conservation and DNA damage-responsiveness of the mammalian gadd45 gene. J. Biol. Chem., 268: 24385–24393, 1993.
30. 1 cyclin-dependent kinases. Cell, 75: 805–816, 1993.
31. 1 arrest and apoptosis. Cancer Res., 54: 1169–1174, 1994.
32. 1 arrest. Cell, 76: 1013–1023, 1994.
33. Xiong, Y., Zhang, H., and Beach, D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 505–514, 1992.
34. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell. Res., 211: 90–98, 1994.
35. Gu, Y., Turck, C. W., and Morgan, D. O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707–710, 1993.
36. Bhatia, K., Goldschmidts, W., Gutierrez, M., Gaidano, G., Dalla-Favera, R., and Magrath, I. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect. FASEB J., 7; 951–956, 1993.
37. O’Connor, P. M., Wassermann, K., Sarang, M., Magrath, I., Bohr, V. A., and Kohn, K. W. Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt’s lymphoma cell lines differing in sensitivity to nitrogen mustard. Cancer Res., 51: 6550–6557, 1991.
38. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156–159, 1987.
39. Hollander, M. C., and Fornace, A. J., Jr. Estimation of relative mRNA content by filter hybridization to a polythymidylate probe. Biotechniques, 9: 174–179, 1990.
40. Hollander, M. C., and Fornace, A. J., Jr. Induction of fos RNA by DNA-damaging agents. Cancer Res., 49: 1687–1692, 1989.
41. Milner, J., and Medcalf, E. A. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell, 65: 765–774, 1991.
42. Chedid, M., Michieli, P., Lengel, C., Huppi, K., and Givol, D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene, 9: 3021–3024, 1994.
43. Jackman, J., Alamo, I., and Fornace, Jr., A. J. Genotoxic stress confers preferential and coordinate mRNA stability on the five gadd genes. Cancer Res., 54: 5656–5662, 1994.
44. Xiong, Y., Zhang, H., and Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7: 1572–1583, 1993.
45. Sherr, C. J. Mammalian Gl cyclins. Cell, 73: 1059–1065, 1993.
46. Scheffher, M., Huibregtse, J. M., and Howley, P. M. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. USA, 91: 8797–8801, 1994.
47. Finley, D., and Chau, V. Ubiquitination. Annu. Rev. Cell Biol., 7: 25–69, 1991.
48. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., and Cho, K. R. Human papillomavirus 16 E6 expression disrupts the p53 mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA, 90: 3988–3992, 1993.
49. 1 cell cycle checkpoint pathway involving p53, pRB, and pRB-related proteins. Proc. Natl. Acad. Sci. USA, 91: 5320–5324, 1994.
50. Qin, X., Livingston, D. M., Kaelin, W. G., Jr., and Adams, P. D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 91: 10918–10922, 1994.
51. Hermeking, H., and Eick, D. Mediation of c-Myc-induced apoptosis by p53. Science (Washington DC), 265: 2091–2093, 1994.
52. 1 arrest. Proc. Natl. Acad. Sci. USA, 91: 10079–10083, 1994.
53. White, A., Livanos, E. M., and Tlsty, T. D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev., 8: 666–677, 1994. NIH, MD 20892.
54. Fan, S., Smith, M. L., River, D. J., II, Duba, D., Zhan, Q., Kohn, K. W., Fornace, A. J., Jr., and O’Connor, P. M. Disruption of p53 function sensitizes breast cancer MCF-7 cells to Cisplatin and Pentoxifyline. Cancer Res., 55: 1649–1654, 1995.
55. Bhatia, K., Fan, S., Spangler, G., Weintraub, M., O’Connor, P. M., Judde, J. G., Magrath, I. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt’s lymphoma. Cancer Res., 55: 1431–1435, 1995.